StreetAlpha.app
Home › Stocks › PRCT

PROCEPT BioRobotics Corp (PRCT)

$24.70
▼ −4.08%
LAST CLOSE · NOV 20

PROCEPT BioRobotics makes robotic systems that use imaging and a waterjet to remove prostate tissue, mainly for hospitals. It last closed at $24.70 on Nov 20, down 4.08% on the day. The next earnings report for PRCT is expected around Wed, Feb 24, 2027, after the close. For the quarter ended Sep 2026, PRCT reported EPS of -$0.46 on revenue of $98.3M, with revenue up 18.0% from a year ago. Over its last 8 reports the stock moved an average of 8.4% the session after earnings. Over the last 12 months PRCT insiders bought $11.0M of stock on the open market and sold $717K, according to SEC Form 4 filings.

AI Auto Pilots
Is PRCT in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold PRCT.

Key Stats

Last 12 months
Results
Revenue
$352.3M
+17.5% vs a year ago
Net income
−$114.9M
−32.6% margin
EPS (diluted)
−$2.02
Free cash flow
−$85.1M
−24.1% margin
Valuation
Market cap
$1.4B
57.5M shares
P/E
–
No P/E while losing money
Price to sales
4.0
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$218.4M
At Sep 30
Debt
$51.8M
At Sep 30
Shareholder equity
$328.9M
Shares outstanding
57.5M
At Oct 29
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $34.5M$34.5MFY2021FY2022: $75.0M$75.0MFY2022FY2023: $136.2M$136.2MFY2023FY2024: $224.5M$224.5MFY2024FY2025: $308.1M$308.1MFY2025

From PRCT's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 4). Last 12 months adds up the four latest quarters.

Next report
Feb 24
Estimated date · After the close
Reported EPS
-$0.46
Quarter ended Sep 2026
Year ago EPS
-$0.38
Same quarter last year
Revenue
$98.3M
+18.0% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.34Dec '24Mar 2025: -$0.45Mar '25Jun 2025: -$0.35Jun '25Sep 2025: -$0.38Sep '25Dec 2025: -$0.53Dec '25Mar 2026: -$0.56Mar '26Jun 2026: -$0.47Jun '26Sep 2026: -$0.46Sep '26Latest -$0.46
Revenue by quarter
Dec 2024: $68.2MDec '24Mar 2025: $69.2MMar '25Jun 2025: $79.2MJun '25Sep 2025: $83.3MSep '25Dec 2025: $76.4MDec '25Mar 2026: $83.1MMar '26Jun 2026: $94.5MJun '26Sep 2026: $98.3MSep '26Latest $98.3M
How PRCT moved after its last 8 reports
Average move the session after a report ±8.4%
Nov 4, 2026After the close−6.4%
Aug 4, 2026After the close+5.8%
Apr 29, 2026After the close+10.7%
Feb 25, 2026After the close−15.1%
Nov 4, 2025After the close−9.7%
Jul 24, 2025After the close−5.0%
Apr 24, 2025Time not announced−5.6%
Feb 25, 2025After the close+8.6%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on PRCTStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on PRCT
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on PRCT

Technical Analysis

PRCT · as of the Nov 20 close · updated each morning
Bounce inside a longer downtrend, nearing overbought

The stock is 11% above its 20 day and 20% above its 50 day average. It is 8% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 66), near overbought. The nearest support is the Pivot S1 at $24.05, and the nearest resistance the Pivot at $25.29.

Short trendBullish
Long trendBearish
MomentumStrong
StretchNear overbought
VolatilityHigh, 5.7%/day
Key levels
$38.1152 week high+54.3%
$28.82Swing high (Jun 1)+16.7%
$25.95Pivot R1+5.1%
$25.29Pivot+2.4%
$24.70Last close
$24.05Pivot S1−2.6%
$23.03Swing low (Nov 17)−6.8%
$22.80200 day average−7.7%
$22.0320 day average−10.8%
$20.04100 day average−18.9%
$19.8750 day average−19.6%
$16.6652 week low−32.6%
Indicators
RSI (14)66.22Strong, overbought above 70Neutral
MACD1.51Above its signal lineBullish
Stochastic85.8Near the top of its rangeOverbought
ADX (14)45.1Strong uptrend
Williams %R-24.4Oversold below −80, overbought above −20Neutral
CCI (20)119.6Oversold below −100, overbought above 100Overbought
Rate of change+19.8%Change over 10 sessionsBullish
ATR (14)$1.41Typical daily range, 5.7% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for PRCT

What happened before

See how PRCT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow PRCT usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How PRCT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for PRCTHow many large options trades hit PRCT, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

PRCT Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●108 buying vs 123 selling
  • ▼Held by funds -0.6 pts
  • ▼Funds holding -25
  • ▲Superinvestors: 2 added, 0 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding232257−9.7%
In funds' top 1000–
Held by funds94.8%95.3%−0.6 pts
New / increased26 / 8236 / 109−25.5%
Reduced / sold out72 / 5165 / 37+20.6%
Put/call ratio1.940.48+299.8%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See PRCT institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

PRCT Insider Trading

All filings →
Insider trading · 12 months
Insiders are net buyers
Bought$11.0M2 buys · 2 insiders
Sold$717K13 sales · 4 insiders
19% of the selling was under pre-arranged trading plans.
2026-03 bought $10.5M2026-03 sold $573K2026-06 sold $28K2026-08 bought $498K2026-09 sold $22K2026-11 sold $93KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 6Pooja SharmaChief Strat/Marketing OfficerSale4,710$19.71$93K
Sep 9Barry L TemplinEVP, Chief Technology OfficerSale373$20.95$8K
Sep 9Alaleh NouriEvp, Clo, Corp. Sec.Sale297$20.95$6K
Sep 9Kevin WatersEvp, CFOSale373$20.95$8K
Aug 7Larry L WoodPresident, CEOBuy23,900$20.85$498K
Jun 8Barry L TemplinEVP, Chief Technology OfficerSale358$28.48$10K
Every insider buy and sale for PRCT over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See PRCT insider trades →

From SEC Form 4 filings by PRCT's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PRCT is in one of them and how their past PRCT trades turned out.

PRCT in the AI portfolios
Loading…

PRCT News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered PRCT in an article yet. Here's the latest on the wider market.

PRCT in the news

About PROCEPT BioRobotics

PROCEPT BioRobotics makes surgical robots used to treat benign prostatic hyperplasia, a common condition in which the prostate gland enlarges and is not cancerous. Its AquaBeam and HYDROS robotic systems use a disposable handpiece, real time imaging and a waterjet that removes prostate tissue without heat. The company sells mainly to hospitals in the United States, with some sales through distribution partners, ambulatory surgery centers and leasing companies, and it sells to customers in other countries through its sales team and distribution partners. It is based in San Jose, California.

Headquarters
San Jose, CA